OCUL - Ocular Therapeutix, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$25.50
DETAILS
HIGH:
$30.00
LOW:
$21.00
MEDIAN:
$25.50
CONSENSUS:
$25.50
UPSIDE:
209.84%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 87.3% |
| EBIT Margin | -490.3% |
| EBITDA Margin | -482.0% |
| Operating Margin | -521.0% |
| Pretax Margin | -513.2% |
| Cont. Ops Margin | -513.2% |
| Net Margin | -513.2% |
| Bottom Line Margin | -513.2% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 15.39 |
| Quick Ratio | 15.32 |
| Solvency Ratio | -1.702 |
| Cash Ratio | 14.51 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-8.55
Peers avg: 39.4
|
| PEG Ratio | -0.52 |
| Forward PEG | -0.52 |
| Price/Book | 3.47 |
| Price/Sales | 43.86 |
| Price/FCF | -10.48 |
| Price/Op Cash Flow | -11.09 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0987 |
| Debt/Equity | 0.1219 |
| Debt/Capital | 0.1087 |
| Long-Term Debt/Capital | 0.1018 |
| Financial Leverage | 1.23 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.09 |
| Operating Cash Flow Ratio | -4.033 |
| Operating Cash Flow/Sales | -395.4% |
| Free Cash Flow/Operating Cash Flow | 105.9% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -17.05 |
| Interest Coverage | -22.8151 |
| Short-Term Operating Cash Flow Coverage | -72.73 |
| Operating Cash Flow Coverage | -2.57 |
| Capital Expenditure Coverage | -17.06 |
| Dividend + Capital Expenditure Coverage | -17.06 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.28 |
| EPS | -1.420 |
| Debt/Share | 0.4893 |
| Cash/Share | 3.94 |
| Book Value/Share | 3.49 |
| Tangible BV/Share | 3.49 |
| Equity/Share | 3.49 |
| Operating Cash Flow/Share | -1.094 |
| Capital Expenditure/Share | 0.064 |
| FCF/Share | -1.158 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.985 |
| Price/Fair Value | 3.47 |
| Debt/Market Cap | 0.0339 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -6.47 |